SCHEMBL13493396

SCHEMBL13493396

Cc1cc2cc(-c3c(Cl)nc(N(C)C)nc3N[C@@H]3C[C@H](CO)C[C@H]3C)oc2c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12058523 0.92 — —
SCHEMBL12058390 0.80 IRAK4 (0.38) —
SCHEMBL13493429 0.79 IRAK4 (0.35) —
SCHEMBL13493573 0.78 IRAK4 (0.36) —
SCHEMBL12058492 0.78 IRAK4 (0.30) —
SCHEMBL12037592 0.77 IRAK4 (0.40) —
SCHEMBL12037856 0.77 IRAK4 (0.45) —
SCHEMBL13493495 0.77 IRAK4 (0.35) —
SCHEMBL12058472 0.76 IRAK4 (0.40) —
SCHEMBL13493546 0.75 IRAK4 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2010-02-25 — — WO disclosed
Send feedback